Brief: AbbVie To Acquire Landos Biopharma

Landos Biopharma

25/03/2024 14:07

March 25 (Reuters) - Abbvie Inc  ABBV.N :
    * ABBVIE TO ACQUIRE LANDOS BIOPHARMA, FURTHER STRENGTHENING
ITS
PORTFOLIO IN INFLAMMATORY AND AUTOIMMUNE DISEASES
    * ABBVIE INC - UNDER TERMS OF AGREEMENT, ABBVIE WILL ACQUIRE
LANDOS AT A PRICE OF $20.42 PER SHARE IN CASH UPON CLOSING
    * ABBVIE INC - PROPOSED TRANSACTION IS EXPECTED TO CLOSE IN
SECOND
CALENDAR QUARTER OF 2024
    * ABBVIE-PROPOSED DEAL INCLUDES ONE NON-TRADABLE CONTINGENT
VALUE
RIGHT PER SHARE OF UP TO $11.14, OR ABOUT ADDITIONAL $75 MILLION
ON ACHIEVING SOME MILESTONES

Source text for Eikon:  ID:nGNX7M6Nyk 
Further company coverage:  ABBV.N 

 ((Reuters.Briefs@thomsonreuters.com;))